ES8606659A1 - Un metodo para detectar anticuerpos en suero o fluido - Google Patents

Un metodo para detectar anticuerpos en suero o fluido

Info

Publication number
ES8606659A1
ES8606659A1 ES536211A ES536211A ES8606659A1 ES 8606659 A1 ES8606659 A1 ES 8606659A1 ES 536211 A ES536211 A ES 536211A ES 536211 A ES536211 A ES 536211A ES 8606659 A1 ES8606659 A1 ES 8606659A1
Authority
ES
Spain
Prior art keywords
detected
stabilization
destabilization
response
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES536211A
Other languages
English (en)
Other versions
ES536211A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elan Pharmaceuticals LLC
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of ES536211A0 publication Critical patent/ES536211A0/es
Publication of ES8606659A1 publication Critical patent/ES8606659A1/es
Expired legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
    • G01N2800/101Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/104Lupus erythematosus [SLE]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/829Liposomes, e.g. encapsulation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Mycology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)

Abstract

UN METODO PARA DETECTAR ANTICUERPOS EN SUERO O FLUIDO. LA PRESENCIA DE ANTICUERPOS AFINES EN MUESTRA DE ENSAYO SE DETECTA POR ALTERACION DE LA ESTRUCTURA SUPRAMOLECULAR DE LOS LIPOSOMAS, QUE TIENE COMO RESULTADO UNOS CAMBIOS DE ESTABILIZACION. LA DESESTABILIZACION SE PUEDE DETECTAR, Y EN CIERTOS CASOS PUEDE SER CAUSADA, POR ADICION DE IONES MAGNESIO O CALCIO. LA ESTABILIZACION AUMENTADA SE PUEDE DETECTAR POR LA POLIMERIZACION DE LOS COMPONENTES DE LA BICAPA COMO RESPUESTA A LUZ ULTRAVIOLETA. LAS INTERACCIONES ANTICUERPO-ANTIGENO EN LA SUPERFICIE DEL LIPOSOMA MEDIATIZAN LA RESPUESTA DE ESTABILIZACION/DESESTABILIZACION.
ES536211A 1983-09-26 1984-09-25 Un metodo para detectar anticuerpos en suero o fluido Expired ES8606659A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/535,884 US4668638A (en) 1983-03-24 1983-09-26 Liposome composition for lupus assay

Publications (2)

Publication Number Publication Date
ES536211A0 ES536211A0 (es) 1986-04-01
ES8606659A1 true ES8606659A1 (es) 1986-04-01

Family

ID=24136197

Family Applications (1)

Application Number Title Priority Date Filing Date
ES536211A Expired ES8606659A1 (es) 1983-09-26 1984-09-25 Un metodo para detectar anticuerpos en suero o fluido

Country Status (9)

Country Link
US (1) US4668638A (es)
EP (1) EP0138685A3 (es)
JP (1) JPS61500182A (es)
AU (1) AU3436684A (es)
DK (1) DK234785D0 (es)
ES (1) ES8606659A1 (es)
GR (1) GR80483B (es)
WO (1) WO1985001580A1 (es)
ZA (1) ZA847573B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622871A (en) 1987-04-27 1997-04-22 Unilever Patent Holdings B.V. Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
US4957735A (en) * 1984-06-12 1990-09-18 The University Of Tennessee Research Corporation Target-sensitive immunoliposomes- preparation and characterization
US4801459A (en) * 1986-08-05 1989-01-31 Liburdy Robert P Technique for drug and chemical delivery
US5190761A (en) * 1986-08-05 1993-03-02 Liburdy Robert P Electromagnetic field triggered drug and chemical delivery via liposomes
US4962022A (en) * 1986-09-22 1990-10-09 Becton Dickinson And Company Storage and use of liposomes
EP1248112A3 (en) 1987-04-27 2004-08-25 Inverness Medical Switzerland GmbH Immunochromatographic specific binding assay device
JPH0194261A (ja) * 1987-07-13 1989-04-12 Univ Tennessee Res Corp 酵素関与するアッセイのために、均一系でリポソームを利用してシグナルを増幅する方法
US5258503A (en) * 1987-09-08 1993-11-02 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Autoantibody adsorbent and apparatus for removing autoantibodies using the same
US4913902A (en) * 1987-11-10 1990-04-03 North Carolina State University Purification by affinity binding to liposomes
US5167925A (en) * 1988-06-08 1992-12-01 North Carolina State University Precipitation of multivalent antiligands with affinity surfactants
US5112770A (en) * 1988-06-08 1992-05-12 North Carolina State University Precipitation of multivalent antiligands with affinity surfactants
US6352862B1 (en) * 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
WO1990015594A1 (en) * 1989-06-16 1990-12-27 Liburdy, Robert, P. Electromagnetic field triggered drug and chemical delivery via liposomes
ATE142789T1 (de) * 1989-10-19 1996-09-15 Yamasa Shoyu Kk Träger zur bindung von antiphospholipid- antikörpern, diese antikörper verwendender immunotest und kit dafür
FR2657885A1 (fr) * 1990-02-08 1991-08-09 Cird Anticorps capables de reconnaitre specifiquement un antigene du stratum corneum de l'epiderme humain, leur preparation et leur application, notamme comme vecteurs de drogues.
US5556637A (en) * 1990-08-06 1996-09-17 A. Nattermann & Cie. Gmbh Water containing liposome system
EP0772778B1 (en) 1994-07-23 1999-10-27 Roche Diagnostics GmbH Method for the determination of the prethrombotic state
US5776487A (en) * 1996-04-19 1998-07-07 Pasteur Sanofi Diagnostics Liposome reagents for immunoassays
US5780319A (en) * 1996-04-19 1998-07-14 Pasteur Sanofi Diagnostics Immunoassays to detect antiphospholipid antibodies
WO1998004743A1 (en) * 1996-07-29 1998-02-05 The Regents Of The University Of California Polymeric assemblies for sensitive colorimetric assays

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235792A (en) * 1977-04-14 1980-11-25 The Governing Council Of The University Of Toronto Immunological materials
US4193983A (en) * 1978-05-16 1980-03-18 Syva Company Labeled liposome particle compositions and immunoassays therewith
US4234563A (en) * 1978-06-02 1980-11-18 American Hospital Supply Corporation Insolubilized deoxyribonucleic acid (DNA)
US4255411A (en) * 1978-11-27 1981-03-10 Damon Corporation Process of determining an immunogenic substance by competition with an antibody in a microcapsule
GB2026340B (en) * 1978-07-03 1982-12-22 Ash P Stabilising microvesicles
DE3000483A1 (de) * 1979-01-09 1980-07-17 Fuji Photo Film Co Ltd Mikrokapseln fuer immunologische bestimmungen
US4372745A (en) * 1979-12-19 1983-02-08 Electro-Nucleonics, Inc. Chemical luminescence amplification substrate system for immunochemistry involving microencapsulated fluorescer
US4342826A (en) * 1980-02-04 1982-08-03 Collaborative Research, Inc. Immunoassay products and methods
US4329331A (en) * 1980-03-13 1982-05-11 Kallick Charles A Diagnostic method for detection of systemic lupus erythematosus
US4483921A (en) * 1981-01-12 1984-11-20 Collaborative Research, Inc. Immunoassay with antigen or antibody labeled liposomes sequestering enzyme
JPS5842971A (ja) * 1981-09-07 1983-03-12 Fuji Photo Film Co Ltd 抗体を感作させたマイクロカプセルを用いる細胞性免疫測定法
US4483929A (en) * 1982-05-03 1984-11-20 Liposome Technology Incorporated Liposomes with glycolipid-linked antibodies

Also Published As

Publication number Publication date
US4668638A (en) 1987-05-26
DK234785A (da) 1985-05-24
ZA847573B (en) 1985-05-29
JPS61500182A (ja) 1986-01-30
WO1985001580A1 (en) 1985-04-11
GR80483B (en) 1985-01-28
AU3436684A (en) 1985-04-23
ES536211A0 (es) 1986-04-01
EP0138685A2 (en) 1985-04-24
DK234785D0 (da) 1985-05-24
EP0138685A3 (en) 1988-04-27

Similar Documents

Publication Publication Date Title
ES8606659A1 (es) Un metodo para detectar anticuerpos en suero o fluido
GB9113211D0 (en) Support membrane
ES2115679T3 (es) Preparacion de reactivos de tiempo de protrombina a partir de factor de tejido humano recombinante y de fosfolipidos sinteticos y naturales purificados.
IE860253L (en) Foam treatment of fibrous materials
AU525403B2 (en) Purified antigen
ES2070820T3 (es) Anticuerpos monoclonales especificos de la apolipoproteina b, producidos por dos nuevos hibridomas.
ES481817A1 (es) Procedimiento para determinar magnitudes reologicas carac- teristicas de materiales viscosos.
KR850001496A (ko) 흡착 공정
KR910012042A (ko) 투명한 수지조성물
FI845103L (fi) Fotometriskt foerfarande foer bestaemmande av koncentrationen i reaktioner, vilka foerloeper under bildande eller foerbrukande av spridningscentraler.
KR920004582A (ko) 가죽의 플레싱 방법
KR910011281A (ko) 혈청으로부터 알파-1-안티트립신의 분리 정제 및 혈중 알파-1-안티트립신 양의 검정키트
KR890014394A (ko) 탈수오니케이크의 소취방법
ATE41529T1 (de) Verfahren zur immunologischen bestimmung einer substanz in einer fluessigen probe.
ATE77487T1 (de) Immunologisches bestimmungsverfahren zur bestimmung von hapteneigenschaften aufweisenden freien substanzen.
JPS56113493A (en) Developer sheet for no-carbon copying paper
JPS5345588A (en) Sludge densitometer
JPS5653465A (en) Improved method in measurement of enzyme immunity
KR870002274A (ko) 슬래그(slag)연화제
DE3484279D1 (de) Loesungsmittelgemisch zur bestimmung des saeuregehalts von in mit dytel-freongasen betriebenen kuehlanlagen verwendetem oel.
SU1818954A1 (ru) Способ определения коэффициента вытеснения нефти
SU661294A1 (ru) Устройство дл определени содержани газов растворенных в жидкости
KR890002666A (ko) 혈청리파제의 측정을 위한 개선된 비탁방법
JPS5436796A (en) Humidity sensitive element
KR910001378A (ko) HIV p24 정량 패널